Skip to content

Quality improvement project evaluating the impact of preoperative MRI on the reduction of positive histological margins and reoperations in patients eligible for breast conserving therapy

Quality improvement project evaluating the impact of preoperative MRI on the reduction of positive histological margins and reoperations in patients eligible for breast conserving therapy - Preoperative MRI in patients with breast cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON30682
Enrollment
120
Registered
2007-03-15
Start date
2007-04-01
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diagnostisch onderzoek met als doel tot een optimale planning voor borstsparende chirurgie te komen voor patiënten met mammacarcinoom Breast cancer

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - breast cancer patients eligible for breast conserving therapy - signed informed consent

Exclusion criteria

Exclusion criteria: - contra-indications for MRI - pregnancy

Design outcomes

Primary

MeasureTime frame
Reduction of irradical lumpectomies The primary goal of additional preoperative imaging and discussion is to reduce the rate of irradical lumpectomies. The histology reports of the specimen will be the reference standard. Assessment of irradicallity will be judged according to national guidelines. The percentage of lumpectomy specimens with positive margins will be documented and compared to that in the historical control group.

Secondary

MeasureTime frame
- Reduction of re-operations The number and percentage of re-operations will be documented and compared to that in the historical control group. - Accuracy of tumor size estimation Histology reports of the specimens of all patients will be compared with the outcomes of clinical examination and breast imaging with and without MRI in order to assess extent of tumor and size in mm*s. Correlation coefficients versus histology (as reference standard) will be calculated for the sizes determined by conventional workup and by MRI. - Sensitivity and specificity of the imaging modalities in diagnosing tumor size and extent Histology (as reference standard) of the specimens of all patients will be compared with the outcomes of breast imaging with and without MRI in order to assess sensitivity and specificity of the imaging modalities, and especially MRI, in diagnosing size and extent of the tumor. - Cost-effectiveness of preoperative MRI Finally, a cost-effectiveness analysis of preoperative MRI will be performed, taking into account the costs of clinical examination, the preoperative imaging procedures, the costs of the initial surgical procedures and re-operations, and the effectiveness of radical versus irradical treatment.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)